Moreover, increased immunohistochemical expression of AQP1 in bioptic and surgical have been reported to predict improved overall survival (OS) in patients affected by mesothelioma, HER2-positive early breast cancer, colorectal cancer, and biliary tract carcinoma. This evidence concerns the gene AQP1 and colorectal cancer.